[Ag2(aca)2]n and [Ag4(aca)4(NH3)2] (acaH = 9-anthracenecarboxylic acid): Synthesis, X-ray crystal structures, antimicrobial and anti-cancer activities

Inorganic Chemistry Communications

Volumn 10, Issue 10, 2007, Pages 1149-1153

  Curran, Robert ^a   Lenehan, Joanne ^a   McCann, Malachy ^a   Kavanagh, Kevin ^a   Devereux, Michael ^b   Egan, Denise A ^b   Clifford, Grace ^b   Keane, Kevin ^b   Creaven, Bernadette S ^b   McKee, Vickie ^c  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^c LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

9 Anthracenecarboxylic acid; Anti bacterial; Anti cancer; Anti fungal; Silver(I); X ray structure

Indexed keywords

EID: 34548637971     PISSN: 13877003     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.inoche.2007.06.021     Document Type: Article

References (15)

1. Rowan R., Tallon T., Sheahan A.M., Curran R., McCann M., Kavanagh K., Devereux M., and McKee V. Polyhedron 25 (2006) 1771
2. Creaven B.S., Egan D.A., Kavanagh K., McCann M., Noble A., Thati B., and Walsh M. Inorg. Chim. Acta 359 (2006) 3976
3. Thati 92.B., Noble A., Rowan R., Creaven B.S., Walsh M., McCann M., Egan D., and Kavanagh K. Toxicol. In Vitro 21 (2007) 801
4. Coyle B., McCann M., Kavanagh K., Devereux M., McKee V., Kayal N., Egan D., Deegan C., and Finn G.J. J. Inorg. Biochem. 98 (2004) 1361
5. McCann M., Coyle B., McKay S., McCormack P., Kavanagh K., Devereux M., McKee V., Kinsella P., O'Connor R., and Clynes M. BioMetals 17 (2004) 635
6. Deegan C., McCann M., Devereux M., Coyle B., and Egan D.A. Cancer Lett. 247 (2007) 224
7. 6): 3.04 ppm (s), 7.47 (m), 8.08 (m), singlet 8.44 (s).
8. 2 using all the reflections [9]. All the non-hydrogen atoms were refined using anisotropic atomic displacement parameters and hydrogen atoms were inserted at calculated positions using a riding model.
9. Sheldrick G.M. shelxtl Version 6.12 (2001), Bruker AXS, Madison WI
10. Mehrotra R.C., and Bohra R. Metal Carboxylates (1983), Academic Press Inc., London
11. 50 values (minimum concentration required to inhibit 50% of cell growth). Experiments were performed in triplicate and the data analysed using Microsoft Excel.
12. McCann M., Geraghty M., Devereux M., O'Shea D., Mason J., and O'Sullivan L. Metal-Based Drugs 7 (2000) 185
13. Coyle B., Kavanagh K., McCann M., Devereux M., and Geraghty M. BioMetals 16 (2003) 321
14. 50 was calculated and is defined as the drug concentration (μM) causing a 50% reduction in cellular viability. The significance of any reduction in cellular viability was determined using one-way ANOVA (analysis of variance). A probability of 0.05 or less was deemed statistically significant.
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: applications to proliferation and cytotoxicity assays. J. Immunol. 65 (1983) 55-63